Press Release Details

Cerus Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference

January, 26 2009
CONCORD, Calif., Jan 26, 2009 (BUSINESS WIRE) -- Cerus Corporation (NASDAQ:CERS) announced today that company management will present at the 11th Annual BIO CEO & Investor Conference in New York City. Cerus' presentation will begin at 10:30 a.m. EST on Monday, February 9, 2009. To access the live webcast, please log on to the company's website at An archived presentation will be available on the website until February 16, 2009.


Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The Company is also pursuing regulatory approvals in the United States and other countries. The INTERCEPT red blood cell system is currently in clinical development.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

SOURCE: Cerus Corporation

Cerus Corporation
William J. Dawson, 925-288-6053
Vice President, Finance & CFO

    Global Headquarters

  • 1220 Concord Avenue
  • Concord, CA US 94520
  • +1 925.288.6000

    European Headquarters

  • Stationsstraat 79-D
  • 3811 MH Amersfoort, Netherlands
  • +31 (0) 33 49 60 600